phase1oncology.com

What It Is

Phase1Oncology is a boutique pharmaceutical consulting firm headquartered in Cambridge, Massachusetts and New York, United States. Its core business focuses on filling the gap between preclinical research of oncology drugs and their first-in-human Phase I clinical trials, providing end-to-end specialized support for Phase I development to pharmaceutical and biotech companies of all sizes.

Core Features & Services

The firm offers a complete service chain from project planning to study completion, covering:

• Oncology drug development strategy planning
• Competitive landscape analysis
• End-to-end assistance for IND (Investigational New Drug) applications
• Writing of investigator brochures and clinical study protocols
• Selection of trial sites and KOLs

-推动 IRB 审批推进

• CRO selection and project monitoring
• Daily medical monitoring by board-certified US oncologists to protect subject safety
• Regular data analysis
• Final complete clinical trial report and subsequent development recommendations

The depth of involvement can be flexibly adjusted to client needs: clients can choose to outsource the entire project or participate deeply in the process.

Pros, Cons & Target Users

Pros:

• The team consists of senior experts across multiple domains including medicine, biostatistics, strategy and regulatory affairs, with strong professional expertise
• Adopts a multi-task parallel advancement approach that effectively shortens project timelines
• All solutions are fully customized to fit the client's budget and project requirements

Cons:

• Pricing is not publicly disclosed on the official website
• Services are exclusively focused on Phase I oncology development
• Primarily serves the North American market

This service is ideal for US biotech startups and established pharmaceutical companies that need to advance new oncology drugs into Phase I clinical trials.

Accessibility from China

The website is currently directly accessible in China, no proxy tool is required.